Federal award (PURCHASE ORDER, fiscal year 2021)
Recipient: BIOCOMX
Awarding agency: Department of Health and Human Services / National Institutes of Health
Funding agency: Department of Health and Human Services / National Institutes of Health
Period of performance: 2021-01-28 to 2022-01-27
Current total value of award: $14871750
Description: EO14042 - THE PURPOSE OF THIS MODIFICATION IS TO INCLUDE FAR DEVIATION CLAUSE 52.223-99 - ENSURING ADEQUATE COVID SAFETY PROTOCOLS FOR FEDERAL CONTRACTORS PURSUANT WITH EXECUTIVE ORDER 14042.